The Company is a Korea-based company principally engaged in the manufacture and distribution of veterinary medicines. The Company in control of the technology include hybridoma cell fusion technology, monoclonal antibody bank, recombinant expression, lateral flow technology, stabilization technology and other veterinary medicine technology. The Company distributes its products within domestic market and to overseas markets. The Company was founded on October 18, 1999 and its shares are listed on KOREA NEW EXCHANGE(KONEX) on June 26, 2017.
Headquarters
878, Sunhwan-Daero, Dongnae-Myeon, Chuncheon-Si, Gangwon-Do, Korea
Chuncheon; Gangwon;
Contact Details: Purchase the Median Diagnostics Inc. report to view the information.
Website: http://www.mediandiagnostics.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service